Earlier this week, The Cooper Companies reported second-quarter 2026 results showing record sales of US$1,081.5 million but a net loss of US$77.9 million, largely due to a US$271.6 million litigation charge tied to a 2023 CooperSurgical product recall.
The company paired this with updated full-year 2026 revenue guidance of about US$4.29–US$4.32 billion, confirmation of stronger non‑GAAP earnings, and completion of a long-running share repurchase program totaling over US$1.14 billion, signaling confidence in its underlying operations and balance sheet.
Next, we’ll examine how record revenue alongside the substantial recall-related litigation charge reshapes Cooper Companies’ investment narrative and risk profile.
The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 13 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
Cooper Companies Investment Narrative Recap
To own Cooper Companies, you need to believe its core eye care and fertility businesses can keep growing despite legal and operational setbacks. The latest quarter reinforces that tension: record US$1,081.5 million in sales supports the long term lens and fertility demand story, while the US$271.6 million recall litigation charge and resulting net loss keep CooperSurgical’s recall as the key near term overhang and the primary swing factor for both sentiment and execution risk.
Against that backdrop, the completion of more than US$1,140.3 million in share repurchases under the long running buyback program is particularly relevant. It highlights how management is still allocating substantial capital to shareholders even as it works through recall related costs and modestly trimmed full year revenue guidance to about US$4.29 to US$4.32 billion, which may influence how investors weigh the MyDAY and fertility growth catalysts against recall and litigation risk.
Yet behind the record revenue, investors should still be aware of how recall litigation, fertility market volatility and Asia Pacific pricing pressure could…
Read the full narrative on Cooper Companies (it’s free!)
Cooper Companies’ narrative projects $4.9 billion revenue and $829.7 million earnings by 2029. This requires 5.4% yearly revenue growth and an earnings increase of about $428 million from $401.4 million today.
Uncover how Cooper Companies’ forecasts yield a $87.14 fair value, a 29% upside to its current price.
Exploring Other Perspectives 
COO 1-Year Stock Price Chart
Some of the lowest estimating analysts were already assuming revenue of about US$4.7 billion and earnings near US$808.6 million by 2029, so this litigation driven quarter could either reinforce their more cautious margin view or prompt them to revisit how much recall and CooperSurgical risk you should price in.
Explore 5 other fair value estimates on Cooper Companies – why the stock might be worth 35% less than the current price!
Reach Your Own Conclusion
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Looking For Alternative Opportunities?
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include COO.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com